Sebastian Noe

10PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapyImmunogenetics (incl. genetic immunology)Predictive and prognostic markersBehavioural epidemiologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 03, 2025
Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practice.

Hannes Höller, Anna Ivanova, Farhad Schabaz

|Oct 25, 2021
Humoral response to SARS-CoV-2 vaccines in people living with HIV.

Sebastian Noe, Nino Ochana, Carmen Wiese

|Jan 02, 2021
HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'.

S Noe, F Schabaz, S Heldwein

|Jan 29, 2019
Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort.

Sebastian Noe, Silke Heldwein, Carmen Wiese

|Jan 12, 2019
Tenofovir disoproxil fumarate/emtricitabine is associated with a higher risk of hypocalcemia compared to abacavir/lamivudine - results from a German cohort study.

S Noe, S Heldwein, H Jaeger

|Sep 25, 2018
Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study.

Sebastian Noe, Christine I Moeckel, Christiane Schwerdtfeger

Pageof 2

Frequent Collaborators

1 joint publications

Christoph D Spinner

1 joint publications

Eva Wolf